Engineered red blood cells as an off-the-shelf allogeneic anti-tumor therapeuticXuqing Zhang, Tiffany F. Chen|Nature Communications|2021Cited by 58
Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis: a prospective multicenter randomized open-label studyXiaoning Wu, Hong You, Mingyi Xu et al.|Expert Opinion on Biological Therapy|2018Cited by 44
On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in <scp>HBV</scp>‐related compensated cirrhosisShanshan Wu, Jidong Jia, Yuanyuan Kong et al.|Liver International|2017Cited by 41
Dexamethasone protects normal human liver cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand by upregulating the expression of P-glycoproteinsBo Zhao, Xuqing Zhang, Gui-Juan Xie et al.|Molecular Medicine Reports|2012Cited by 13